Only one patient with refractory disease was found to have rearrangement of MYC and BCL6. Of the 58 patients with rrDLBCL, diagnostic pretreatment biopsies and post-treatment biopsies obtained after the progression of tumor were available for 29 patients and 47 patients, respectively. This evidence concerns the gene MYC and neoplasm.